Reuters logo
BRIEF-Aurinia Pharmaceuticals reports Q2 loss per share $‍0.03​
August 10, 2017 / 8:45 PM / 3 months ago

BRIEF-Aurinia Pharmaceuticals reports Q2 loss per share $‍0.03​

Aug 10 (Reuters) - Aurinia Pharmaceuticals Inc-

* Aurinia reports second quarter 2017 financial results, and provides operational highlights

* Aurinia Pharmaceuticals Inc qtrly loss per share $‍0.03​

* Aurinia Pharmaceuticals - ‍believe, based on current plans, co has financial resources to complete aurora trial and regulatory submission process​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below